東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Regulation of autoreactive B cells d...

The University of North Carolina at Chapel Hill., Biology, Microbiology.

FindBook

Google Book

Amazon

博客來

Regulation of autoreactive B cells during innate immune responses.

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Regulation of autoreactive B cells during innate immune responses./
作者:	Rutan, Jennifer Ann.
面頁冊數:	85 p.
附註:	Source: Dissertation Abstracts International, Volume: 69-11, Section: B, page: 6558.
Contained By:	Dissertation Abstracts International69-11B.
標題:	Biology, Microbiology. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoeng/servlet/advanced?query=3335417
ISBN:	9780549900580

Regulation of autoreactive B cells during innate immune responses.
Rutan, Jennifer Ann.

Regulation of autoreactive B cells during innate immune responses. - 85 p.

Source: Dissertation Abstracts International, Volume: 69-11, Section: B, page: 6558.

Thesis (Ph.D.)--The University of North Carolina at Chapel Hill, 2008.

A diverse repertoire of B cell specificities is critical to combat pathogenic threats, but this diversity is tinged with the threat of autoimmunity. Autoimmune diseases such as systemic lupus erythematosus (SLE) underscore the need for strict regulation of B cell activation during immune responses. Regulation of the adaptive immune response is dependent on B cell receptor (BCR) ligation, affinity of the BCR-antigen interaction, and the presence of costimulatory molecules. Mechanisms of central tolerance and peripheral tolerance eradicate B cells that inappropriately bind self-antigens. Autoreactive B cells that escape these mechanisms of tolerance and encounter antigen in the absence of costimulatory signals enter an unresponsive state known as anergy. Anergic B cells do not differentiate into plasma cells, activate transcription factors such as Blimp-1 and XBP-1, or secrete immunoglobulin (Ig). B cells can also be activated by toll-like receptor (TLR) ligands and contribute to the innate immune response, the first line of defense against pathogens. Bacterial and viral components are the archetypical TLR ligands, but endogenous DNA and RNA can also bind TLRs and activate the innate immune system. Therefore, it is critical to regulate the innate immune response to prevent autoimmunity, and this regulation requires unique mechanisms that are not necessarily dependent on BCR ligation. Ideally, these mechanisms would also discriminate between naive and chronically antigen-experienced B cells, allowing naive B cells to respond to threats while potentially autoreactive B cells remain quiescent. We have recently described a mechanism where antigen-experienced B cells are regulated by IL-6 and sCD40L released by dendritic cells (DCs) and macrophages (Mphis) during innate immune responses. Naive B cells are unaffected by these factors, permitting a robust immune response in the absence of autoimmunity. IL-6/sCD40L-mediated repression is dependent on ERK activation and "repressed" antigen-experienced cells exhibit a decrease in activated ERK in the nucleus. Identifying new targets for SLE therapies could enable specific regulation of antigen-experienced B cells instead of non-specific B cell depletion and immunosuppression.

ISBN: 9780549900580Subjects--Topical Terms:

1017734
Biology, Microbiology.

Regulation of autoreactive B cells during innate immune responses.
LDR:03326nam 2200313 a 45 001 858254
005 20100712
008 100712s2008 ||||||||||||||||| ||eng d
020 $a 9780549900580
035 $a (UMI)AAI3335417
035 $a AAI3335417
040 $a UMI $c UMI
100 1 $a Rutan, Jennifer Ann. $3 1025299
245 1 0 $a Regulation of autoreactive B cells during innate immune responses.
300 $a 85 p.
500 $a Source: Dissertation Abstracts International, Volume: 69-11, Section: B, page: 6558.
502 $a Thesis (Ph.D.)--The University of North Carolina at Chapel Hill, 2008.
520 $a A diverse repertoire of B cell specificities is critical to combat pathogenic threats, but this diversity is tinged with the threat of autoimmunity. Autoimmune diseases such as systemic lupus erythematosus (SLE) underscore the need for strict regulation of B cell activation during immune responses. Regulation of the adaptive immune response is dependent on B cell receptor (BCR) ligation, affinity of the BCR-antigen interaction, and the presence of costimulatory molecules. Mechanisms of central tolerance and peripheral tolerance eradicate B cells that inappropriately bind self-antigens. Autoreactive B cells that escape these mechanisms of tolerance and encounter antigen in the absence of costimulatory signals enter an unresponsive state known as anergy. Anergic B cells do not differentiate into plasma cells, activate transcription factors such as Blimp-1 and XBP-1, or secrete immunoglobulin (Ig). B cells can also be activated by toll-like receptor (TLR) ligands and contribute to the innate immune response, the first line of defense against pathogens. Bacterial and viral components are the archetypical TLR ligands, but endogenous DNA and RNA can also bind TLRs and activate the innate immune system. Therefore, it is critical to regulate the innate immune response to prevent autoimmunity, and this regulation requires unique mechanisms that are not necessarily dependent on BCR ligation. Ideally, these mechanisms would also discriminate between naive and chronically antigen-experienced B cells, allowing naive B cells to respond to threats while potentially autoreactive B cells remain quiescent. We have recently described a mechanism where antigen-experienced B cells are regulated by IL-6 and sCD40L released by dendritic cells (DCs) and macrophages (Mphis) during innate immune responses. Naive B cells are unaffected by these factors, permitting a robust immune response in the absence of autoimmunity. IL-6/sCD40L-mediated repression is dependent on ERK activation and "repressed" antigen-experienced cells exhibit a decrease in activated ERK in the nucleus. Identifying new targets for SLE therapies could enable specific regulation of antigen-experienced B cells instead of non-specific B cell depletion and immunosuppression.
590 $a School code: 0153.
650 4 $a Biology, Microbiology. $3 1017734
650 4 $a Health Sciences, Immunology. $3 1017716
690 $a 0410
690 $a 0982
710 2 $a The University of North Carolina at Chapel Hill. $b Biology, Microbiology. $3 1025298
773 0 $t Dissertation Abstracts International $g 69-11B.
790 $a 0153
790 1 0 $a Arnold, Larry W. $e committee member
790 1 0 $a Clarke, Stephen H. $e committee member
790 1 0 $a Frelinger, Jeffrey A. $e committee member
790 1 0 $a Ting, Jenny P. Y. $e committee member
790 1 0 $a Vilen, Barbara J. $e committee member
791 $a Ph.D.
792 $a 2008
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoeng/servlet/advanced?query=3335417